January 7, 2016 8:43 PM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT) announces that it has acquired Montreal based, privately held, Biodroga Inc. for $15 million in a combination of cash and stock. All amounts in Canadian dollars. Biodroga is a leading solution provider of omega-3's and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. Their customized product offerings primarily include omega-3's, along with other essential nutritional ingredients that are used in specialty formulations. Biodroga develops and distributes these solutions as turnkey finished supplements that are ready for sale, primarily as softgel capsules and liquids. The business combination is highly complementary and further positions Neptune for success, by adding a new growth vehicle in a significantly larger addressable market. "Biodroga offers a scalable solutions platform,
See full press release
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.